| Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732) |
|---|
| 04/21/2004 | CN1146455C 1,2,4,5-tetrahydro-benzo[d] azepine compound |
| 04/15/2004 | WO2004031248A1 Novel nitrosation polymer in organic synthesis |
| 04/15/2004 | WO2004031155A1 ENANTIOSELECTIVE PROCESS FOR THE PREPARATION OF BOTH ENANTIOMERS OF 10,11-DIHYDRO-10-HYDROXY-5H-DIBENZ [b,f]AZEPINE-5-CARBOXAMIDE AND NEW CRYSTAL FORMS THEREOF |
| 04/15/2004 | WO2004031154A1 Novel lactams and uses thereof |
| 04/15/2004 | WO2004014391B1 Use of carboxamides for the treatment of tinnitus |
| 04/15/2004 | CA2501237A1 Enantioselective process for the preparation of both enantiomers of 10,11-dihydro-10-hydroxy-5h-dibenz [b,f]azepine-5-carboxamide and new crystal forms thereof |
| 04/15/2004 | CA2500754A1 Novel nitrosation polymer in organic synthesis |
| 04/14/2004 | EP1131297B1 Certain substituted caprolactams, pharmaceutical compositions containing them and their use in treating tumors |
| 04/14/2004 | EP1109781B1 Process to continuously prepare an aqueous mixture of epsilon-caprolactam and epsilon-caprolactam precursors |
| 04/14/2004 | CN1145612C New 1-aza-2-alkyl-6-aryl-cyclanes compound, its producing process and medical composition containing them |
| 04/08/2004 | WO2004028538A1 Small organic molecules that increase the activity of gelatinase a in ocular cells |
| 04/08/2004 | WO2003068732A3 Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds |
| 04/08/2004 | US20040068017 Small organic molecules that increase the activity of Gelatinase A in ocular cells |
| 04/08/2004 | US20040067981 Acetylcholinesterase inhibitor; Alzheimer's diseases, Hubtington disease, antidepressants |
| 04/08/2004 | CA2500200A1 Small organic molecules that increase the activity of gelatinase a in ocular cells |
| 04/07/2004 | CN1144788C Bicycle vasporession agonists |
| 04/06/2004 | US6716977 Method for making caprolactam from impure ACN wherein ammonia and water are removed from crude caprolactam in a simple separation step and then THA is removed from the resulting caprolactam melt |
| 04/01/2004 | WO2003066597A3 Guanidino compounds |
| 04/01/2004 | US20040063725 Binding neuropeptide Y receptors; hypertension, angina, atherosclerosis, depression, anxiety, inflammation, allergies |
| 04/01/2004 | US20040063699 Gpr14 antagonist |
| 03/31/2004 | CN1486309A Tetrahydroazepine derivatives useful as dopamine d3 receptor modulators (antipsychotic agents) |
| 03/31/2004 | CN1486184A Lactam compound to inhibit beta-amyloid peptide release or synthesis |
| 03/30/2004 | US6713476 Substituted cycloalkyls as inhibitors of a beta protein production |
| 03/30/2004 | US6713471 Such as tert-butyl-1-methyl-6,7,9,12-tetrahydro-5h-pyrido-(4,3-b)(1,4) thiazepino(2,3,4-hi)indole-11(10h)-carboxylate; serotonin agonists and antagonists; central nervous system disorders |
| 03/30/2004 | US6713467 Anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and metastasis inhibitors in treating cancer |
| 03/30/2004 | US6713036 Mixing feed stream and oxidant using small scale multilamination mixing to yield reactant stream having characteristic mixing time; reacting with characteristic reaction time in reaction zone in presence of catalyst |
| 03/25/2004 | WO2004024702A1 Novel carboxamide compounds having an mch-antagonistic effect, medicaments containing said compounds, and methods for the production thereof |
| 03/25/2004 | WO2003086306B1 5ht2c receptor modulators |
| 03/25/2004 | WO2003082260A3 Tuberculosis treatment using pleuromutilin derivatives |
| 03/25/2004 | US20040058912 Psychological disorders; eating disorders; dietetics |
| 03/25/2004 | US20040058900 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 03/25/2004 | CA2496563A1 New carboxamide compounds having mch-antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture |
| 03/24/2004 | EP1399431A2 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 03/24/2004 | EP1399424A1 Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and 10,11-dihydro-10-0x0-5h-dibenz/b,f/azepine-5-carboxamide |
| 03/24/2004 | CN1484636A Method for storing and transporting N-vinyl caprolactam |
| 03/24/2004 | CN1484633A N (phenylsulphonyl) glycine derivatives and their therapentic use |
| 03/24/2004 | CN1483725A Method for producing cycloheximide and technology thereof |
| 03/24/2004 | CN1142916C Dopamine D1 receptor agonist compounds |
| 03/24/2004 | CN1142911C Compounds with growth hormone releasing properties |
| 03/24/2004 | CN1142907C Process to continuously prepare aqueous mixture of epsi-caprolacta and epsi caprolactam precursors |
| 03/23/2004 | US6710058 Use as anticoagulant agents for therapy and prophylaxis ofthromboembolic disorders |
| 03/18/2004 | WO2003079975A3 Process for the manufacture of optically active 3-substituted lactams by asymmetric hydrogenation of 3-alkylidenelactams |
| 03/18/2004 | US20040053933 Ligands of melanocortin receptors and compositions and methods related thereto |
| 03/18/2004 | US20040053920 Administering to a patient suffering from caspase mediated diseses, an effective amount of a mono,bi or tri-heterocyclic ring containing nitrogen atom attached to ester or thioester to form carbamate group, as caspase inhibitor |
| 03/18/2004 | US20040053826 Uses of polypeptides |
| 03/17/2004 | EP1397340A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 03/17/2004 | EP1240140B1 Method for the production of n-alkenyl amides |
| 03/17/2004 | EP1140936B1 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 03/17/2004 | CN1142139C Hydrofinishing method of caprolactam |
| 03/16/2004 | CA2096460C Dual action inhibitors |
| 03/11/2004 | US20040049038 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease |
| 03/11/2004 | US20040048851 Amidinophenylalanine derivatives as thrombin inhibitors |
| 03/11/2004 | US20040048346 Synthesis of chiral intermediates useful in preparing pharmacologically active compounds |
| 03/11/2004 | DE10238865A1 New carboxamides are melanin-concentrating hormone receptor antagonists, useful for treating e.g. metabolic diseases, diabetes, eating disorders, cardiovascular disease, emotional disorders, reproductive and memory disorders |
| 03/10/2004 | EP1395560A1 2-oxo-piperidinyl- and 2-oxo-azepanyl alkanoic acid derivativ es for the treatment of epilepsy and other neurological disorders |
| 03/10/2004 | CN2606105Y Electric foreign ions remover with caprolactam |
| 03/10/2004 | CN1481380A Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists |
| 03/10/2004 | CN1481377A Cyclic Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF alhpa |
| 03/10/2004 | CN1481358A Carboxylic acid amide derivatives and their use in treatment of thromboembolic diseases and tumours |
| 03/10/2004 | CN1481241A Therapeutic combination of amlodipine and benazepril/benazeprilat |
| 03/09/2004 | US6703501 Porous catalyst for preparing epsilon-caprolactam from cyclohexanone oxime in vapor phase, comprising layered silicate and metal oxides pillared between silicate layers, having specified interlayer distance and surface area |
| 03/04/2004 | WO2004018432A1 Substituted azepines as histamine h3 receptor antagonists, preparation and therapeutic uses |
| 03/04/2004 | WO2004017911A2 Protease inhibitors |
| 03/04/2004 | US20040044201 Bone disorders; osteoporosis; oral diseases; antiarthritic agents |
| 03/04/2004 | US20040044200 Method of preparing a 5H-dibenz(b,f)azepine-5-carboxamide |
| 03/04/2004 | US20040043977 Alzheimer's disease |
| 03/03/2004 | EP1394870A2 Organic light emitting device |
| 03/03/2004 | EP1392317A2 Substituted 1-benzazepines and derivatives thereof |
| 03/03/2004 | EP1392307A1 Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene |
| 03/02/2004 | US6699988 By reacting phosgene and lactam in the presence of a non-nucleophilic aliphatic tertiary amine, such as n,n-diisopropylethylamine; high purity, good yields |
| 02/26/2004 | US20040038962 Treatment of nocturnal enuresis, nocturia, polyuria resulting from central diabetes insipidus, urinary incontinence or bleeding disorders such a hemophilia |
| 02/26/2004 | US20040038858 Carboxamide derivatives and their use in the treatment of thromboembolic diseases and tumours |
| 02/25/2004 | EP1390366A1 The citrate salt of 5,8,14,-triazatetracyclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaene |
| 02/19/2004 | WO2004014391A1 Use of carboxamides for the treatment of tinnitus |
| 02/19/2004 | WO2003086306A3 5ht2c receptor modulators |
| 02/19/2004 | US20040034250 Nitrosylating (with nitrosyl tetrafluoroborate) in presence of base then hydrolyzing to give hydroxy-imino derivative, followed by hydrogenation; for production of benazepril |
| 02/19/2004 | US20040034018 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders |
| 02/19/2004 | US20040034015 Administering to a human patient suffering from addictive behavior associated with 5HT2C receptor modulation, a fused tetra or pentaheterocyclic compound containing nitrogen in the rings |
| 02/19/2004 | US20040033986 Anti tubercular drug: compositions and methods |
| 02/19/2004 | CA2494660A1 Use of carboxamides for the treatment of tinnitus |
| 02/18/2004 | EP1389189A2 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 02/18/2004 | EP1389103A2 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents |
| 02/18/2004 | CN1476434A Novel compounds |
| 02/12/2004 | WO2004013105A1 Crystalline polymorphic and amorphous forms of benazepril hydrochloride |
| 02/12/2004 | WO2004012726A2 Methods for treatment and prevention of gastrointestinal conditions |
| 02/12/2004 | US20040030129 NF-kappaB inhibitor comprising phenylmethyl benzoquinone as an active ingredient |
| 02/12/2004 | US20040029905 Using codeine, hydrocodeine, meptazinol, tilidine, propoxyphene |
| 02/12/2004 | US20040029863 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 02/12/2004 | US20040029862 Alzheimer's disease |
| 02/12/2004 | CA2494284A1 Methods for treatment and prevention of gastrointestinal conditions |
| 02/12/2004 | CA2492949A1 Crystalline polymorphic and amorphous forms of benazepril hydrochloride |
| 02/10/2004 | US6689784 Controlling cell apoptosis |
| 02/10/2004 | CA2180301C Substituted dihydrodibenzo/b,f/azepines, method of their preparation, their use in the treatment of some central nervous system disorders, and pharmaceutical compositions containing them |
| 02/10/2004 | CA2176836C The preparation of caprolactam |
| 02/05/2004 | WO2004011431A1 Pleuromutilin derivatives as antimicrobbials |
| 02/04/2004 | EP1385826A1 Method for preparation of (s)-(+)- and (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide |
| 02/04/2004 | EP1385818A2 Biurethane derivatives |
| 02/04/2004 | EP1385517A1 Novel oral general anesthetics and metabolitically resistant anticonvulsants |
| 02/04/2004 | EP1098875B1 Method for cyclizing hydrolysis of an aminonitrile compound into lactam |
| 02/03/2004 | US6686477 Multistep chemical synthesis, including asymmetric hydrogenation of a lactam-enamide to produce an intermediate that can be used to make unspecified pharmaceuticals |